Sch-66336 (Sarasar®) and Other Benzocycloheptapyridyl Farnesyl Protein Transferase Inhibitors: Discovery, Biology and Clinical Observations

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 10, 2003-01 ,pp. : 1103-1114

Bentham Science Publishers

Access to resources Recommend Favorite

Farnesyl transferase inhibitors in the treatment of breast cancer

By Kelland Lloyd R  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 413-421

Informa Healthcare

Access to resources Recommend Favorite

Farnesyl Transferase Inhibitors as Potential Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 19, 2018-11 ,pp. : 1611-1623

Bentham Science Publishers

Access to resources Recommend Favorite

Controlled Exploration of Structural Databases: The Case of Farnesyl Transferase Inhibitors

By  

Medicinal Chemistry, Vol. 5, Iss. 3, 2009-05 ,pp. : 208-215

Bentham Science Publishers

Access to resources Recommend Favorite

Heteronemin as a Protein Farnesyl Transferase Inhibitor

By Ledroit Véronique   Debitus Cécile   Ausseil Frédéric   Raux Roselyne   Menou Jean-Louis   Hill Bridget  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 42, Iss. 6, 2004-09 ,pp. : 454-456

Informa Healthcare

Access to resources Recommend Favorite